Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype-Reference-Cited by-同舟云学术

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype

Published:2014-09-16 Issue:6 Volume:30 Page:805-812
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Swanson Christine R.¹,Li Katherine¹,Unger Travis L.¹,Gallagher Michael D.¹²,Van Deerlin Vivianna M.³,Agarwal Pinky⁴,Leverenz James⁵,Roberts John⁶,Samii Ali⁷,Gross Rachel Goldmann¹,Hurtig Howard¹,Rick Jacqueline¹,Weintraub Daniel⁸,Trojanowski John Q.³,Zabetian Cyrus⁷,Chen-Plotkin Alice S.¹

Affiliation:

1. Department of Neurology; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania USA

2. Cellular and Molecular Biology Graduate Group; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania USA

3. Department of Pathology and Laboratory Medicine; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania USA

4. Booth Gardner Parkinson's Care Center; Evergreen Hospital Medical Center; Kirkland Washington USA

5. Cleveland Clinic Ruvo Center for Brain Health; Cleveland Ohio USA

6. Virginia Mason Medical Center; Seattle Washington USA

7. VA Puget Sound Health Care System and Department of Neurology; University of Washington Seattle; Seattle Washington USA

8. Department of Psychiatry; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference43 articles.

1. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries;Wright Willis;Neuroepidemiology,2010

2. Ageing and Parkinson's disease: substantia nigra regional selectivity;Fearnley;Brain,1991

3. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease;Rader;Ann Intern Med,1994

4. Plasma apolipoprotein A1 as a biomarker for Parkinson disease;Qiang;Ann Neurol,2013

5. Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects;Maarouf;Neurol Res,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies;Metabolites;2024-06-22

2. Lipoprotein Particles in Cerebrospinal Fluid;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-05

3. Systematic analysis of multi-omics data reveals component-specific blood-based biomarkers for Parkinson’s disease;Translational Medicine Communications;2024-04-23

4. Single nucleotide polymorphisms in apolipoprotein A-I (rs670) and B (rs693) associated with serum lipoproteins and endothelial activation in COVID-19 outpatients;Brazilian Journal of Pharmaceutical Sciences;2024

5. Circadian Regulation of Apolipoproteins in the Brain: Implications in Lipid Metabolism and Disease;International Journal of Molecular Sciences;2023-12-12